Electronic Cigarettes clinical trials at UC Cancer

• Short-Term Cardiovascular Effects of E-Cigarettes: Influence of Device Power

  open to eligible people ages 21 years and up

  This study will examine the short-term cardiovascular (CV) effects of e-cigarette device power in a randomized, crossover clinical and behavioral pharmacology study of experienced adult e-cigarette users (N=21). The specific aim is to determine the impact of e-cigarette power on nicotine pharmacology, systemic exposure to toxic volatile organic compounds (VOCs), and short-term cardiovascular effects.

  at UCSF

• Short-Term Cardiovascular Effects of E-Cigarettes: Influence of E-Liquid pH

  open to eligible people ages 21-70

  This study will examine the short-term cardiovascular (CV) effects of e-liquid pH in a randomized, crossover clinical and behavioral pharmacology study of experienced adult e-cigarette users (N=21). The specific aim of the study is to assess the impact of changes in e-liquid pH on nicotine pharmacokinetics, cardiovascular, and subjective effects of e-cigarettes.

  at UCSF

Last updated: June 3, 2021